The leukaemia epigenome targeted

Julie-Aurore Losman ()
Additional contact information
Julie-Aurore Losman: Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts 02215, USA.

Nature, 2017, vol. 543, issue 7647, 634-635

Abstract: Modification of methyl groups attached to DNA alters gene expression, and mutations that deregulate this methylation are common in some leukaemias. Drugs that target aberrant methylation are emerging as promising therapeutics.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/543634a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:543:y:2017:i:7647:d:10.1038_543634a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/543634a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().